Over the last few weeks, the UK’s medical cannabis industry has been written about in The Times, The Guardian, the...
The second quarter of 2026 has brought tentative signs of stabilisation to a cannabis sector that spent much of 2025...
The Irish government has appointed a public health academic to chair a formal review of its now five-year-old Medical Cannabis...
US Medicare patients have now been given access to cannabidiol (CBD) products through a landmark federal pilot scheme, helping boost...
As the UK’s medical cannabis industry continues to come under fierce scrutiny from the country’s mainstream media, James Duckenfield, CEO...
Zurich’s municipal parliament has voted to extend its flagship adult-use cannabis pilot, Züri Can, by a further two years to...
On the second anniversary of Germany’s landmark Cannabis Act (CanG) coming into force, the most comprehensive data and analysis of...
Written by Ben Stevens & Sarah Sinclair A new campaign is calling for urgent regulatory changes to how medical cannabis...
The UK CBD industry’s long and hard-fought battle to become the first in the world to receive official regulatory approval...
The White House’s commitment to push through rescheduling has been challenged by a Democratic Senator, who has demanded answers on...
Six weeks after the US Food and Drug Administration (FDA) failed to meet its 90-day deadline to clarify which cannabinoids...
Next week will mark the second anniversary of the implementation of Germany’s landmark Cannabis Act (CanG), which came into force...
The UK and Germany’s medical cannabis markets both more than doubled in size throughout 2025, once again cementing the countries...
Bipartisan lawmakers have reintroduced a bill to the House of Representatives that would provide a pathway for cannabis businesses to...
For the first time in over 5 decades, the Indian government has granted public funding to a cannabis research project,...
New Zealand’s medical cannabis market grew a further 25% in 2025, according to the latest official figures, seeing the country...
Nearly a decade after the inception of what we would now consider the ‘global cannabis industry’, Prohibition Partners forecasts its...
A major new systematic review has concluded that the available evidence rarely justifies the routine prescribing of cannabinoids for mental...
